Acyl chain-dependent effect of lysophosphatidylcholine on human neutrophils

Journal of Leukocyte Biology

Volumn 82, Issue 6, 2007, Pages 1501-1509

  Ojala, P J ^a   Hirvonen, T E ^a   Hermansson, M ^b   Somerharju, P ^b   Parkkinen, J ^a,c  

^a FINNISH RED CROSS BLOOD SERVICE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Albumin; Free fatty acids; Ischemia; NADPH oxidase; Superoxide

Indexed keywords

ALBUMIN; CALCIUM; FATTY ACID; LYSOPHOSPHATIDYLCHOLINE; PHOSPHOLIPID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STEARIC ACID; SUPEROXIDE;

ARTICLE; BLOOD CELL; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; NEUTROPHIL; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ALBUMINS; CALCIUM SIGNALING; CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; FATTY ACIDS, NONESTERIFIED; HUMANS; L-LACTATE DEHYDROGENASE; LYSOPHOSPHATIDYLCHOLINES; NEUTROPHILS; ONIUM COMPOUNDS; REACTIVE OXYGEN SPECIES; TRYPAN BLUE;

EID: 37249067483     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0507292     Document Type: Article

References (46)

1. Zalewski, A., Macphee, C. H. (2005) Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target. Arterioscler. Thromb. Vasc. Biol. 25, 923-931.
2. Muralikrishna Adibhatla, R., Hatcher, J. F. (2006) Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Radic. Biol. Med. 40, 376-387.
3. Kougias, P., Chai, H., Lin, P. H., Lumsden, A. B., Yao, Q., Chen, C. (2006) Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis. Med. Sci. Monit. 12, RA5-RA16.
4. Daleau, P. (1999) Lysophosphatidylcholine, a metabolite which accumulates early in myocardium during ischemia, reduces gap junctional coupling in cardiac cells. J. Mol. Cell. Cardiol. 31, 1391-1401.
5. Fuchs, B., Schiller, J., Wagner, U., Hantzschel, H., Arnold, K. (2005) The phosphatidylcholine/lysophosphatidylcholine ratio in human plasma is an indicator of the severity of rheumatoid arthritis: investigations by 31P NMR and MALDI-TOF MS. Clin. Biochem. 38, 925-933.
6. Iwase, M., Sonoki, K., Sasaki, N., Ohdo, S., Higuchi, S., Hattori, H., Iida, M. (2007) Lysophosphatidylcholine contents in plasma LDL in patients with type 2 diabetes mellitus: relation with lipoprotein-associated phospholipase A(2) and effects of simvastatin treatment. Atherosclerosis, Epub ahead of print.
7. Pietilainen, K. H., Sysi-Aho, M., Rissanen, A., Seppanen-Laakso, T., Yki-Jarvinen, H., Kaprio, J., Oresic, M. (2007) Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects - a monozygotic twin study. PLoS ONE 2, e218.
8. Silliman, C. C., Clay, K. L., Thurman, G. W., Johnson, C. A., Ambruso, D. R. (1994) Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J. Lab. Clin. Med. 124, 684-694.
9. Silliman, C. C., Voelkel, N. F., Allard, J. D., Elzi, D. J., Tuder, R. M., Johnson, J. L., Ambruso, D. R. (1998) Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J. Clin. Invest. 101, 1458-1467.
10. Thumser, A. E., Voysey, J. E., Wilton, D. C. (1994) The binding of lysophospholipids to rat liver fatty acid-binding protein and albumin. Biochem. J. 301, 801-806.
11. Ojala, P. J., Hermansson, M., Tolvanen, M., Polvinen, K., Hirvonen, T., Impola, U., Jauhiainen, M., Somerharju, P., Parkkinen, J. (2006) Identification of -1 acid glycoprotein as a lysophospholipid binding protein. Biochemistry 45, 14021-14031.
12. Kugiyama, K., Sakamoto, T., Misumi, I., Sugiyama, S., Ohgushi, M., Ogawa, H., Horiguchi, M., Yasue, H. (1993) Transferable lipids in oxidized low-density lipoprotein stimulate plasminogen activator inhibitor-1 and inhibit tissue-type plasminogen activator release from endothelial cells. Circ. Res. 73, 335-343.
13. Huang, F., Subbaiah, P. V., Holian, O., Zhang, J., Johnson, A., Gertzberg, N., Lum, H. (2005) Lysophosphatidylcholine increases endothelial permeability: role of PKCα and RhoA cross talk. Am. J. Physiol. Lung Cell. Mol. Physiol. 289, L176-L185.
14. Ricevuti, G. (1997) Host tissue damage by phagocytes. Ann. N. Y. Acad. Sci. 832, 426-448.
15. Decoursey, T. E., Ligeti, E. (2005) Regulation and termination of NADPH oxidase activity. Cell. Mol. Life Sci. 62, 2173-2193.
16. Bokoch, G. M., Zhao, T. (2006) Regulation of the phagocyte NADPH oxidase by Rac GTPase. Antioxid. Redox Signal. 8, 1533-1548.
17. Lin, P., Welch, E. J., Gao, X. P., Malik, A. B., Ye, R. D. (2005) Lysophosphatidylcholine modulates neutrophil oxidant production through elevation of cyclic AMP. J. Immunol. 174, 2981-2989.
18. Nishioka, H., Horiuchi, H., Arai, H., Kita, T. (1998) Lysophosphatidylcholine generates superoxide anions through activation of phosphatidylinositol 3-kinase in human neutrophils. FEBS Lett. 441, 63-66.
19. Heinloth, A., Heermeier, K., Raff, U., Wanner, C., Galle, J. (2000) Stimulation of NADPH oxidase by oxidized low-density lipoprotein induces proliferation of human vascular endothelial cells. J. Am. Soc. Nephrol. 11, 1819-1825.
20. Takeshita, S., Inoue, N., Gao, D., Rikitake, Y., Kawashima, S., Tawa, R., Sakurai, H., Yokoyama, M. (2000) Lysophosphatidylcholine enhances superoxide anions production via endothelial NADH/NADPH oxidase. J. Atheroscler. Thromb. 7, 238-246.
21. Inoue, N., Takeshita, S., Gao, D., Ishida, T., Kawashima, S., Akita, H., Tawa, R., Sakurai, H., Yokoyama, M. (2001) Lysophosphatidylcholine increases the secretion of matrix metalloproteinase 2 through the activation of NADH/NADPH oxidase in cultured aortic endothelial cells. Atherosclerosis 155, 45-52.
22. Silliman, C. C., Elzi, D. J., Ambruso, D. R., Musters, R. J., Hamiel, C., Harbeck, R. J., Paterson, A. J., Bjornsen, A. J., Wyman, T. H., Kelher, M., England, K. M., McLaughlin-Malaxecheberria, N., Barnett, C. C., Aiboshi, J., Bannerjee, A. (2003) Lysophosphatidylcholines prime the NADPH oxidase and stimulate multiple neutrophil functions through changes in cytosolic calcium. J. Leukoc. Biol. 73, 511-524.
23. Somerharju, P. (2002) Pyrene-labeled lipids as tools in membrane biophysics and cell biology. Chem. Phys. Lipids 116, 57-74.
24. Bartlett, E. M., Lewis, D. H. (1970) Spectrophotometric determination of phosphate esters in the presence and absence of orthophosphate. Anal. Biochem. 36, 159-167.
25. Folch, J., Lees, M., Sloane-Stanley, G. H. (1957) A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226, 497-509.
26. Brügger, B., Erben, G., Sandhoff, R., Wieland, F. T., Lehmann, W. D. (1997) Quantitative analysis of biological membrane lipids at the low picomole level by nano-electrospray ionization tandem mass spectrometry. Proc. Natl. Acad. Sci. USA 94, 2339-2344.
27. Haimi, P., Uphoff, A., Hermansson, M., Somerharju, P. (2006) Software tools for analysis of mass spectrometric lipidome data. Anal. Chem. 78, 8324-8331.
28. Liliom, K., Sun, G., Bunemann, M., Virag, T., Nusser, N., Baker, D. L., Wang, D. A., Fabian, M. J., Brandts, B., Bender, K., Eickel, A., Malik, K. U., Miller, D. D., Desiderio, D. M., Tigyi, G., Pott, L. (2001) Sphingosylphosphocholine is a naturally occurring lipid mediator in blood plasma: a possible role in regulating cardiac function via sphingolipid receptors. Biochem. J. 355, 189-197.
29. Zhu, K., Baudhuin, L. M., Hong, G., Williams, F. S., Cristina, K. L., Kabarowski, J. H., Witte, O. N., Xu, Y. (2001) Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4. J. Biol. Chem. 276, 41325-41335.
30. Kabarowski, J. H., Zhu, K., Le, L. Q., Witte, O. N., Xu, Y. (2001) Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A. Science 293, 702-705.
31. Frasch, S. C., Zemski-Berry, K., Murphy, R. C., Borregaard, N., Henson, P. M., Bratton, D. (2007) Lysophospholipids of different classes mobilize neutrophil secretory vesicles and induce redundant signaling through G2A. J. Immunol. 178, 6540-6548.
32. Bhamidipati, S. P., Hamilton, J. A. (1995) Interactions of lyso-1-palmitoylphosphatidylcholine with phospholipids: a 13C and 31P NMR study. Biochemistry 34, 5666-5677.
33. Brown, M. F. (1994) Modulation of rhodopsin function by properties of the membrane bilayer. Chem. Phys. Lipids 73, 159-180.
34. McCallum, C. D., Epand, R. M. (1995) Insulin receptor autophosphorylation and signaling is altered by modulation of membrane physical properties. Biochemistry 34, 1815-1824.
35. Fink, K. L., Gross, R. W. (1984) Modulation of canine myocardial sarcolemmal membrane fluidity by amphiphilic compounds. Circ. Res. 55, 585-594.
36. DaTorre, S. D., Creer, M. H., Pogwizd, S. M., Corr, P. B. (1991) Amphipathic lipid metabolites and their relation to arrhythmogenesis in the ischemic heart. J. Mol. Cell. Cardiol. 23, 11-22.
37. Salamon, Z., Wang, Y., Brown, M. F., Macleod, H. A., Tollin, G. (1994) Conformational changes in rhodopsin probed by surface plasmon resonance spectroscopy. Biochemistry 33, 13706-13711.
38. Palmgren, M. G., Sommarin, M., Ulvskov, P., Larsson, C. (1990) Effect of detergents on the H(+)-ATPase activity of inside-out and right-side-out plant plasma membrane vesicles. Biochim. Biophys. Acta 1021, 133-140.
39. Flemming, P. K., Dedman, A. M., Xu, S. Z., Li, J., Zeng, F., Naylor, J., Benham, C. D., Bateson, A. N., Muraki, K., Beech, D. J. (2006) Sensing of lysophospholipids by TRPC5 calcium channel. J. Biol. Chem. 281, 4977-4982.
40. Stafford, R. E., Fanni, T., Dennis, E. A. (1989) Interfacial properties and critical micelle concentration of lysophospholipids. Biochemistry 28, 5113-5120.
41. Smith, M., Jungalwala, F. B. (1981) Reversed-phase high performance liquid chromatography of phosphatidylcholine: a simple method for determining relative hydrophobic interaction of various molecular species. J. Lipid Res. 22, 697-704.
42. Cieslik, K., Abrams, C. S., Wu, K. K. (2001) Up-regulation of endothelial nitric-oxide synthase promoter by the phosphatidylinositol 3-kinase γ/Janus kinase 2/MEK-1-dependent pathway. J. Biol. Chem. 276, 1211-1219.
43. Jing, Q., Xin, S. M., Zhang, W. B., Wang, P., Qin, Y. W., Pei, G. (2000) Lysophosphatidylcholine activates p38 and p42/44 mitogen-activated protein kinases in monocytic THP-1 cells, but only p38 activation is involved in its stimulated chemotaxis. Circ. Res. 87, 52-59.
44. Bassa, B. V., Roh, D. D., Vaziri, N. D., Kirschenbaum, M. A., Kamanna, V. S. (1999) Lysophosphatidylcholine activates mesangial cell PKC and MAP kinase by PLCγ-1 and tyrosine kinase-Ras pathways. Am. J. Physiol. 277, F328-F337.
45. Akita, H., Creer, M. H., Yamada, K. A., Sobel, B. E., Corr, P. B. (1986) Electrophysiological effects of intracellular lysophosphoglycerides and their accumulation in cardiac lymph with myocardial ischemia in dogs. J. Clin. Invest. 78, 271-280.
46. Azzazy, H. M., Pelsers, M. M., Christenson, R. H. (2006) Unbound free fatty acids and heart-type fatty acid-binding protein: diagnostic assays and clinical applications. Clin. Chem. 52, 19-29.